Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
Sonia Bortolotti(Biogen (Italy)), Roberto Tonelli(University of Modena and Reggio Emilia)
Cited by 8
Related Papers
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
|Journal of Experimental & Clinical Cancer Research|2022|23